Bvf Inc Curis Inc Transaction History

Bvf Inc

  • $3.27 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$8.78 - $12.8 $5.5 Million - $8.02 Million
-626,945 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$1.08 - $8.2 $3.26 Million - $24.8 Million
-3,023,055 Reduced 82.82%
626,945 $5.14 Million
Q2 2020

Aug 14, 2020
BUY
$0.63 - $1.7 $2.3 Million - $6.21 Million
3,650,000 New
3,650,000 $4.42 Million

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email